Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells

被引:50
作者
Fukuoka, H
Aoyama, M
Miyazawa, K
Asai, K [1 ]
Goto, S
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Mol Neurobiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Aichi Gakuin Univ, Sch Dent, Dept Orthodont, Chikusa Ku, Nagoya, Aichi 4648651, Japan
关键词
osteoclast; hypoxia; differentiation; insulin-like growth factor 2; stromal cell-derived factor 1; receptor activator of nuclear factor-kappa B ligand; DNA microarray; reverse transcription polymerase chain reaction;
D O I
10.1016/j.bbrc.2005.01.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Development of bone depends on a continuous supply of bone-degrading osteoclasts. Although several factors such as cytokines and integrins have been shown to be important for osteoclast recruitment, their mechanism of action is poorly understood. In this study, we demonstrated the enhancement of osteoclast formation by hypoxia and investigated the molecular mechanisms involved. Primary mouse bone marrow cells were cultured in normoxic and hypoxic conditions, and RNA was prepared from each group of cells. Total RNAs were applied to a DNA microarray analysis and then RT-PCR was performed to confirm the microarray data. The most interesting finding of our microarray analysis was upregulation of insulin-like growth factor 2 (IGF2) and stromal cell-derived factor I (SDF1) under hypoxic conditions. RT-PCR analysis revealed that IGF2 expression was markedly upregulated in the non-osteoclastic cells. The addition of exogerious IGF2 increased the number of osteoclastic TRAP-positive multinuclear cells formed under normoxic conditions, whereas the addition of exogenous SDF1 did not change osteoclast formation. These results suggest that the upregulation of IGF2 derived from non-osteoclastic cells might be a crucial factor for osteoclast differentiation. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:885 / 894
页数:10
相关论文
共 39 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   Hypoxia is a major stimulator of osteoclast formation and bone resorption [J].
Arnett, TR ;
Gibbons, DC ;
Utting, JC ;
Orriss, IR ;
Hoebertz, A ;
Rosendaal, M ;
Meghji, S .
JOURNAL OF CELLULAR PHYSIOLOGY, 2003, 196 (01) :2-8
[3]   Chemokines in pathology and medicine [J].
Baggiolini, M .
JOURNAL OF INTERNAL MEDICINE, 2001, 250 (02) :91-104
[4]  
BIDDLE C, 1988, J CELL SCI, V90, P475
[5]   OXYGEN-TENSION OF HEALING FRACTURES IN RABBIT [J].
BRIGHTON, CT ;
KREBS, AG .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1972, A 54 (02) :323-&
[6]   IN VITRO EPIPHYSEAL-PLATE GROWTH IN VARIOUS OXYGEN TENSIONS [J].
BRIGHTON, CT ;
RAY, RD ;
SOBLE, LW ;
KUETTNER, KE .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1969, A 51 (07) :1383-&
[7]   A GROWTH-DEFICIENCY PHENOTYPE IN HETEROZYGOUS MICE CARRYING AN INSULIN-LIKE GROWTH FACTOR-II GENE DISRUPTED BY TARGETING [J].
DECHIARA, TM ;
EFSTRATIADIS, A ;
ROBERTSON, EJ .
NATURE, 1990, 345 (6270) :78-80
[8]   Mechanisms and consequences of activation of protein kinase B/Akt [J].
Downward, J .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (02) :262-267
[9]   Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes [J].
Eggenschwiler, J ;
Ludwig, T ;
Fisher, P ;
Leighton, PA ;
Tilghman, SM ;
Efstratiadis, A .
GENES & DEVELOPMENT, 1997, 11 (23) :3128-3142
[10]   PARENTAL GENOMIC IMPRINTING OF THE HUMAN IGF2 GENE [J].
GIANNOUKAKIS, N ;
DEAL, C ;
PAQUETTE, J ;
GOODYER, CG ;
POLYCHRONAKOS, C .
NATURE GENETICS, 1993, 4 (01) :98-101